Design and Rationale of TRITON-PN, a Phase Three Study to Evaluate the Efficacy of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

Diagnostic Patterns and Clinical Characteristics of Hereditary ATTR Amyloidosis: A Retrospective Study From a U.S. Health System

Clinical Heterogeneity in a Family With Rare F33L Hereditary Transthyretin Amyloidosis: A Case Series of Three Siblings